RxDoctor Payments Data

Patrick Murray, MD

Orthopaedic Surgery · Honolulu, HINPI 1982748356

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. KCI USA, Inc. accounts for 65.4% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $5,186 and has fallen 87.2% since, to $661 in 2025.

$19,488in general payments, 2019–2025

Across 171 payments — averaging $113.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • KCI USA, Inc.$13K
  • Trimed, Inc.$3K
  • Smith+Nephew$1K
  • Si-bone, Inc.$1K
  • Bioventus LLC$507
  • Zimmer Biomet$316
  • plus $882 from 9 others

What the payments were for

  • Consulting fees$7,46938%
  • Speaking & faculty fees$4,50923%
  • Travel & lodging$9355%
  • Food & beverage$6,12531%
  • Education$4502%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,488 in reported general payments places this provider in the 80th percentile of 83 orthopaedic surgery providers in Hawaii.

See all orthopaedic surgery providers in Hawaii

Medicare billing

Part B allowed, 2024
$102,499
Medicare patients
142
Services billed
4,649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$804
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim22$167
Cephalexin23$110
Meloxicam11$62
Tramadol Hcl12$60

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →